CAS: 226711-23-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Bakkenolide Db REF: TM-TN3484CAS: 226711-23-5 | 98% | To inquire | Thu 14 Nov 24 |
 | Bakkenolide Db REF: BP-SBP04122CAS: 226711-23-5 | 95%~99% | To inquire | Mon 18 Nov 24 |
 | Bakkenolide Db REF: 3D-BJA71123CAS: 226711-23-5 | Min. 95% | To inquire | Fri 27 Dec 24 |
Bakkenolide Db
CAS:226711-23-5
Bakkenolide Db may have cytotoxicity.
Formula:
C21H28O7S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
424.51
Ref: TM-TN3484
| 5mg | 618.00 € | ||
| 1mL*10mM (DMSO) | 627.00 € |
Estimated delivery in United States, on Thursday 14 Nov 2024
Ref: BP-SBP04122
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 18 Nov 2024
Bakkenolide Db
CAS:226711-23-5
Bakkenolide Db is a medicine that is used to treat symptoms of ischemic heart disease …
Formula:
C21H28O7S
Purity:
Min. 95%
Molecular weight:
424.5 g/mol
Ref: 3D-BJA71123
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
